Your browser version is outdated. We recommend that you update your browser to the latest version.

DeNovX is ...

an innovative pharmaceutical company that provides platform products for pharmaceutical and medical nutrition uses. 

  • Our pharmaceutical products division is advancing the development of a clinically de-risked drug for the treatment of ulcerative colitis.  For additional information regarding our ulcerative colitis drug please click here.  
  • Our pharmaceutical technology division is focused on the commercialization of products to accelerate pharmaceutical and nutraceutical development while creating new intellectual property (IP) for commercially relevant products.  For additional information regarding our crystal technology products please click here.